The Preimplantation Genetic Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Preimplantation Genetic Testing Market?
The size of the preimplantation genetic testing market has expanded significantly in the recent years. The market, which was valued at $0.83 billion in 2024, is predicted to increase to $0.92 billion in 2025. This growth represents a compound annual growth rate (CAGR) of 11.6%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Preimplantation Genetic Testing Industry?
The preimplantation genetic testing market is projected to increase to $1.41 billion in 2029, with a compound annual growth rate (CAGR) of 11.2%.
Download Your Free Sample of the 2025 Preimplantation Genetic Testing Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Preimplantation Genetic Testing Market?
The key drivers in the preimplantation genetic testing market are:
• Rising number of fertility clinics
• Growth in genetic counseling services
• Growing prevalence of advanced maternal age
• Increasing availability of advanced genetic testing platforms
Global Market Segmentation: Identifying Major Preimplantation Genetic Testing Industry Segments
The preimplantation genetic testing market covered in this report is segmented –
1) By Procedure: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis
2) By Product: Reagents And Consumables, Instruments, Software
3) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridization (FISH), Other Technologies
4) By Application: Chromosomal Abnormalities, Aneuploidy Screening, X-Linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Other Applications
5) By End User: Hospitals, Fertility Centers, Diagnostic Centers, Research Centers And Academic Labs
Subsegments:
1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing, Chromosomal Abnormalities Testing, HLA Typing for Stem Cell Transplantation
Pre-order the 2025 Preimplantation Genetic Testing Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Preimplantation Genetic Testing Market?
The key trends in the preimplantation genetic testing market are:
• The integration of advanced sequencing technologies into the market is a dominant upcoming trend.
• The implementation of expanded genetic panels is also shaping the future of the market.
• The development of non-invasive testing methods is a prominent emerging trend.
• Advancements in both embryo culture systems and genetic editing technologies are pivotal trends in the industry.
Who Are the Top Competitors & Leading Players in the Preimplantation Genetic Testing Market?
Major players in the preimplantation genetic testing market are:
• Thermo Fisher Scientific
• Abbott Laboratories
• Laboratory Corporation of America Holdings
• Agilent Technologies Inc.
• Illumina Inc.
• Revvity Health Science Inc.
• CooperSurgical Inc.
• Natera Inc.
• Progyny Inc.
• Myriad Genetics Inc.
• Fulgent Genetics Inc.
• Invitae Corporation
• Takara Bio Inc.
• MedGenome Labs Ltd.
• Genea Limited
• Ovation Fertility
• Juno Genetics Ltd.
• Invicta Genetics
• Progenesis
• Bioarray SL
• PacGenomics
• Reproductive Genetic Innovations LLC
• SEQUENCE46 LLC
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the preimplantation genetic testing market in 2024
